| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.05 | 0.5 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.028 | 0.7 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.029 | 0.7 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.026 | 0.7 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.00047 | 1 |